F.W. Hoff

No picture available
f.w.hoff umcg.nl


  1. 2020
  2. Hoff, F. W., van Dijk, A. D., Qiu, Y. H., Ruvolo, P. P., Gerbing, R. B., Leonti, A. R., Jenkins, G. N., Gamis, A. S., Aplenc, R., Kolb, E. A., Alonzo, T., Meshinchi, S., De Bont, E., Bruggeman, S. W., Kornblau, S. M., & Horton, T. M. (2020). Heat Shock Factor 1 (HSF1-pSer326) Predicts Response to Bortezomib-Containing Chemotherapy in Pediatric AML: A COG Study. Blood. https://doi.org/10.1182/blood.2020005208
  3. Mirali, S., Botham, A., Voisin, V., Xu, C., St-Germain, J., Sharon, D., Hoff, F. W., Qiu, Y., Hurren, R., Gronda, M., Jitkova, Y., Nachmias, B., MacLean, N., Wang, X., Arruda, A., Minden, M. D., Horton, T. M., Kornblau, S. M., Chan, S. M., ... Schimmer, A. D. (2020). The mitochondrial peptidase, neurolysin, regulates respiratory chain supercomplex formation and is necessary for AML viability. Science Translational Medicine, 12(538), [8264]. https://doi.org/10.1126/scitranslmed.aaz8264
  4. 2019
  5. Hoff, F. W., Hu, C. W., Qutub, A. A., Qiu, Y., Hornbaker, M. J., Bueso-Ramos, C., Abbas, H. A., Post, S. M., de Bont, E. S. J. M., & Kornblau, S. M. (2019). Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse. Proteomics. Clinical Applications, 13(4), [1800133]. https://doi.org/10.1002/prca.201800133
  6. Hoff, F. W., Lu, Y., & Kornblau, S. M. (2019). Antibody Screening. In T. Yamada, SS. Nishizuka, GB. Mills, & LA. Liotta (Eds.), Reverse phase protein arrays: from technical and analytical fundamentals to applications (Vol. 1188, pp. 149-163). (Advances in Experimental Medicine and Biology; Vol. 1188). Springer International Publishing AG. https://doi.org/10.1007/978-981-32-9755-5_8
  7. Dijk, van, A., Hoff, F., & Kornblau, S. M. (2019). Proteomics in Acute Myeloid Leukemia: Guidance to Targeted Therapy Selection and Risk Stratification. In Proteomics: Advances in Research and Applications (pp. 1-38). (Systems Biology – Theory, Techniques and Applications). Nova Science Publishers. https://ebookcentral.proquest.com/lib/rug/reader.action?docID=5981529&ppg=13
  8. 2018
  9. Hoff, F. W., Hu, C. W., Qutub, A. A., Qiu, Y., Graver, E., Hoang, G., Chauhan, M., de Bont, E. S. J. M., & Kornblau, S. M. (2018). Mycoplasma contamination of leukemic cell lines alters protein expression determined by reverse phase protein arrays. Cytotechnology, 70(6), 1529-1535. https://doi.org/10.1007/s10616-018-0244-2
  10. Hoff, F. W., Hu, C. W., Qiu, Y., Ligeralde, A., Yoo, S-Y., Mahmud, H., de Bont, E. S. J. M., Qutub, A. A., Horton, T. M., & Kornblau, S. M. (2018). Recognition of Recurrent Protein Expression Patterns in Pediatric Acute Myeloid Leukemia Identified New Therapeutic Targets. Molecular Cancer Research, 16(8), 1275-1286. https://doi.org/10.1158/1541-7786.MCR-17-0731
  11. Hoff, F. W., Hu, C. W., Qiu, Y., Ligeralde, A., Yoo, S-Y., Scheurer, M. E., de Bont, E. S. J. M., Qutub, A. A., Kornblau, S. M., & Horton, T. M. (2018). Recurrent Patterns of Protein Expression Signatures in Pediatric Acute Lymphoblastic Leukemia: Recognition and Therapeutic Guidance. Molecular Cancer Research, 16(8), 1263-1274. https://doi.org/10.1158/1541-7786.MCR-17-0730
  12. van Dijk, A. D., Hu, C. W., de Bont, E. S. J. M., Qiu, Y., Hoff, F. W., Yoo, S. Y., Coombes, K. R., Qutub, A. A., & Kornblau, S. M. (2018). Histone Modification Patterns Using RPPA-Based Profiling Predict Outcome in Acute Myeloid Leukemia Patients. Proteomics, 18(8), [1700379]. https://doi.org/10.1002/pmic.201700379
  13. 2017
  14. de Bruijn, C. M. A., Hoff, F. W., Bruggeman-Westermann, M. M., Terra, J. B., van Dijk, T. H., de Bont, E. S. J. M., & Peek, A. M. L. (2017). Optimizing VAP scars after childhood cancer treatment: A pilot study. Supportive Care in Cancer, 25(12), 3651-3654. https://doi.org/10.1007/s00520-017-3787-4

ID: 15549699